Retatrutide is a synthetic research compound classified as a triple agonist targeting the GLP-1, GIP, and glucagon receptors. It is currently under scientific investigation for its potential effects on metabolic regulation, energy homeostasis, and body composition research.
By activating GLP-1 and GIP pathways, Retatrutide is studied for its influence on appetite regulation, gastric emptying, and insulin response. In addition, its glucagon receptor activity is being explored for its potential role in increasing energy expenditure and supporting lipid and glycogen metabolism. This combined receptor activity provides a broader metabolic profile compared to single-pathway GLP analogs.
Due to its multi-receptor mechanism, Retatrutide is of interest in advanced metabolic and obesity-related research models. Ongoing studies continue to examine its biological pathways and potential applications in energy balance research.
• Research Grade Compound
• 10, 20, 30MG Vial
• Triple Agonist (GLP-1, GIP, Glucagon)
• Studied for metabolic regulation and energy balance
• Investigational compound for laboratory research only
• Not approved for human or veterinary use
Storage:
Store in a cool, dry environment away from direct sunlight. Keep sealed when not in use.
Disclaimer:
This product is intended strictly for laboratory research purposes only. It is not for human consumption, veterinary use, or diagnostic applications.
Reviews
There are no reviews yet.